Expert Radar
Dr. Michele Cote, PhD, MPH
Director, Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Doctor of Philosophy, University of Michigan
Dr. Michele L. Cote has over 25 years of experience in Molecular Cancer Epidemiology. She earned her BS in Biology from the University of Michigan, her MPH in Epidemiology from the University of Alabama at Birmingham, and her PhD in Epidemiology from the University of Michigan. Formerly, this expert served as the Associate Center Director for Cancer Research Training at the Barbara Ann Karmanos Cancer Institute and as a Professor in the Department of Oncology at Wayne State University School of Medicine. Currently, this expert is the Carrie Glasscock-West Endowed Chair of Breast Carcinogenesis at Indiana University School of Medicine, the Director of Susan G. Komen Tissue Bank at Indiana University Melvin and Bren Simon Comprehensive Cancer Center, and a Professor at the IU Richard M. Fairbanks School of Public Health.
m*********@g*****.com
(317) ***-****
Indianapolis, Indiana
Get a FREE Demo of Dr. Michele Cote, PhD, MPH's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
180
Media & News
318
Social Media Mentions
9
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Case Name | Role | Filed Date |
---|
Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
0
25
50
75
100
Radar found 180 records
Title | Type |
---|---|
Stromal heterogeneity may explain increased incidence of metaplastic breast cancer in women of African descent | Journal Article |
The Association between Mediated Deprivation and Ovarian Cancer Survival among African American Women | Journal Article |
Use of electronic cigarettes among African American cancer survivors | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Radar found 318 records
Title | Description |
---|---|
Seminars and Symposia | Jun 11, 2024 ----- April 26 Dr. Michele Cote seminar: Somatic Mutations in High Grade Endometrial Cancers: Challenges and New Targets ; May 26 Dr. Amir ... |
Faculty Publications March 21-28 | Mar 29, 2024 -- Habeshian, Talar S., Noah C. Peeri, Immaculata De Vivo, Leo J. Schouten, Xiao-Ou Shu, Michele L. Cote, Kimberly A. Bertrand, Yu Chen, Megan ... |
Sequencing Strategies for Population and Cancer ... | Nov 16, 2023 -- Michele Cote, PhD * External Web Site Policy Professor of Oncology ... Professor, Department of Epidemiology and Department of Biostatistics, ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Institution | Degree Type |
---|---|
University of Michigan | Doctor of Philosophy |
University of Alabama at Birmingham | Master of Public Health |
University of Michigan | Bachelor of Science |
Title | Employer |
---|---|
Director | Indiana University Melvin and Bren Simon Comprehensive Cancer Center |
Professor | Indiana University Richard M. Fairbanks School of Public Health |
Carrie Glasscock-West Endowed Chair of Breast Carcinogenesis | Indiana University School of Medicine |
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 3–5 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.